Oragenics Inc OGEN:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/06/22 EDT
0.34quote price arrow down-0.01 (-1.87%)
Volume
18,248
Close
0.3414quote price arrow up+0.0194 (+6.02%)
Volume
178,946
52 week range
0.22 - 1.15
Loading...
  • Open0.3325
  • Day High0.3542
  • Day Low0.3325
  • Prev Close0.3414
  • 52 Week High1.15
  • 52 Week High Date07/27/21
  • 52 Week Low0.22
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap39.74M
  • Shares Out116.39M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.05
  • YTD % Change-23.45

KEY STATS

  • Open0.3325
  • Day High0.3542
  • Day Low0.3325
  • Prev Close0.3414
  • 52 Week High1.15
  • 52 Week High Date07/27/21
  • 52 Week Low0.22
  • 52 Week Low Date05/12/22
  • Market Cap39.74M
  • Shares Out116.39M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.05
  • YTD % Change-23.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-2.43
  • Fwd P/E (NTM)-1.80
  • EBITDA (TTM)-16.551M
  • ROE (TTM)-64.46%
  • Revenue (TTM)100,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-16,191.90%
  • Debt To Equity (MRQ)0.59%

EVENTS

  • Earnings Date08/16/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oragenics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Oragenics, Inc. is a development-stage company that is focused on fighting infectious diseases, including coronaviruses and multidrug-resistant organisms. The Company's lead product, NT-CoV2-1, is an intranasal immunization vaccine candidate to prevent COVID-19 and variants of the SARS-CoV-2 virus. Its other product candidates include Terra CoV-2 and Antibiotics. Terra CoV-2 is an intramuscular vaccine candidate (plasmid + adjuvant) to provide long-lasting immunity against...
Frederick Telling Ph.D.
Executive Chairman of the Board
Kimberly Murphy
President, Chief Executive Officer, Director
Michael Sullivan CPA
Chief Financial Officer, Treasurer, Company Secretary
Address
SUITE 125, 4902 EISENHOWER BLVD
Tampa, FL
33634
United States

Top Peers

SYMBOLLASTCHG%CHG
CYAD
Celyad Oncology SA
1.58-0.06-3.66%
ITRM
Iterum Therapeutics PLC
0.2137-0.0032-1.4753%
NEXI
Neximmune Inc
1.64+0.05+3.14%
COCP
Cocrystal Pharma Inc
0.4001+0.0051+1.29%
TCON
TRACON Pharmaceuticals Inc
1.95+0.02+1.04%